Aguirre FD, Naanous RJ, Vélez PM, Jiménez SR

Language: Spanish
References: 7
Page: 49-52
PDF size: 221.26 Kb.

ABSTRACT

Infective endocarditis continues to be an important cause of morbidity and mortality worldwide, with an annual incidence of three to seven per 100,000 people. Currently, the most important risk factors are degenerative valvular diseases, implantable cardiovascular devices and valve replacement, as well as the use of intravenous drugs. In previous years, the most common risk factor was the presence of rheumatic fever, which has a significative decreasing prevalence because of adequate treatment. We present the clinical case of an 83-year-old woman who began her condition five days before admission, presenting small effort dyspnea, increased respiratory mechanic and sustained fever of 38 ^oC. During her hospital stay, a venous catheter-dependent vegetation was visualized, persistent positive hemocultures were obtained, with Enterococcus faecalis isolation and evidence of a splenic abscess that was punctured by interventional radiology. Initially, she received antibiotic treatment with daptomycin; subsequently, her therapy was changed to double beta-lactam, obtaining negative blood cultures after several days of treatment. Enterococcus faecalis is the third most frequent etiological agent causing infective endocarditis. In our patient, it was possible to isolate this bacteria in both blood cultures and splenic abscess.

REFERENCES

1. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015; 132 (15): 1435-1486.

2. Pericás JM, Zboromyrska Y, Cervera C, Castañeda X, Almela M, Garcia-de-la-Maria C et al. Enterococcal endocarditis revisited. Future Medicine. 2015; 10 (7): 1215-1240.

3. Beganovic M, Luther MK, Rice LB, Arias CA, Rybak MJ, LaPlante KL. A review of combination antimicrobial therapy for Enterococcus faecalis bloodstream infections and infective endocarditis. Clin Infect Dis. 2018; 67 (2): 303-309.

4. McKinnell JA, Kunz DF, Chamot E, Patel M, Shirley RM, Moser SA et al. Association between vancomycin-resistant enterococci bacteremia and ceftriaxone usage. Infect Cont Hosp Epidem. 2012; 33 (7): 718-724.

5. Peterson SC, Lau TTY, Ensom MH. Combination of ceftriaxone and ampicillin for the treatment of enterococcal endocarditis: a qualitative systematic review. Send to Ann Pharmacother. 2017; 51 (6): 496-503.

6. Pericas JM, Llopis J, Cervera C, Sacanella E, Falces C, Andrea R. Infective endocarditis in patients with an implanted transcatheter aortic valve: clinical characteristics and outcome of a new entity. J Infect. 2015; 70 (6): 565-576.

7. The 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015; 36 (44): 3036-3037.